[18F]-Fludarabine for Hematological Malignancies-Reference-Cited by-同舟云学术

[18F]-Fludarabine for Hematological Malignancies

Published:2019-04-17 Issue: Volume:6 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Barré Louisa,Hovhannisyan Narinée,Bodet-Milin Caroline,Kraeber-Bodéré Françoise,Damaj Gandhi

Publisher

Frontiers Media SA

Subject

General Medicine

Reference21 articles.

1. FDG-PET imaging in hematological malignancies;Valls;Blood Rev,2016

2. Personalized management approaches in lymphoma: utility of fluorodeoxyglucose-PET imaging;Ayers;PET Clin,2016

3. Value of 18F-FDG PET/CT in discrimination between indolent and aggressive non-Hodgkin's lymphoma: a study of 328 patients;Alobthani;Hell J Nucl Med,2018

4. PET/MRI in lymphoma;Barrington,2018

5. The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo;Grégoire;Cancer Res.,1994

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ПЭТ-КТ при гематологических злокачественных опухолях: что достигнуто и к чему стремиться;Clinical Oncohematology;2024-04-01

2. FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects;Cancers;2023-02-07

3. Role of Positron Emission Tomography in Primary Central Nervous System Lymphoma;Cancers;2022-08-23

4. Novel insights into the biomarkers and therapies for primary central nervous system lymphoma;Therapeutic Advances in Medical Oncology;2022-01

5. Theranostics of Hematologic Disorders;Nuclear Medicine and Immunology;2021-11-25